Suscribirse

Mucormycosis in Iran: A six-year retrospective experience - 13/06/18

Doi : 10.1016/j.mycmed.2018.02.014 
S. Dolatabadi a, B. Ahmadi b, A. Rezaei-Matehkolaei c, , H. Zarrinfar d, A. Skiada e, H. Mirhendi f, R. Nashibi g, F. Niknejad h, M. Nazeri i, A. Rafiei c, M. Gharaghani j, M. Erami k, S. Taghipour l, F. Piri c, K. Makimura m
a Faculty of Engineering, Sabzevar University of New Technology, Sabzevar, Iran 
b Department of Medical Laboratory Sciences, School of Para-Medicine, Bushehr University of Medical Sciences, Bushehr, Iran 
c Department of Medical Mycology, School of Medicine, Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran 
d Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran 
e Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece 
f Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran 
g Health Research Institute, Infectious and Tropical Diseases Research Center, Infectious Diseases Department, Razi Teaching Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran 
h Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran 
i Department of Medical Parasitology and Mycology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran 
j Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran 
k Shahid Beheshti Hospital, Kashan University of Medical Sciences, Kashan, Iran 
l Department of Medical Parasitology and Mycology, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran 
m Division of Clinical Laboratory Medicine, Graduate School of Medical Care and Technology, Laboratory of Space and Environmental Medicine, Graduate School of Medicine, Teikyo University, Tokyo, Japan 

Corresponding author at: Department of Medical Mycology, School of Medicine, Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.Department of Medical Mycology, School of Medicine, Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

páginas 5
Iconografías 0
Vídeos 0
Otros 0

Abstract

Mucormycosis is a devastating infection caused by Mucoralean fungi (Mucormycotina, Mucorales). Data concerning the global epidemiology of mucormycosis are scarce and little is known about the characteristics of mucormycosis in Iran. In this study, we aimed to understand the distribution of this infection in Iran retrospectively and to ascertain whether the patterns of infection are associated with specific host factors or not. A total of 208 cases were included in this study occurring during 2008–2014 and were validated according to (EORTC/MSG) criteria. A rising trend as significant increase from 9.7% in 2008 to 23.7% in 2014 was observed. The majority of patients were female (51.4%) with median age of 50 and the infections were seen mostly in autumn season (39.4%). Diabetes mellitus (75.4%) was the most common underlying condition and sinus involvement (86%) was the mostly affected site of infection. Amphotericin B (AmB) was the drug of choice for the majority of cases. Sixty four isolates did not show any growth in the lab and only 21 cases were evaluated by ITS sequencing, among them; Rhizopus arrhizus var. arrhizus was the dominant species. Considering the high mortality rate of mucormycosis, early and accurate diagnosis, with the aid of molecular methods may provide accurate treatments and improve the survival rate. Therefore, increased monitoring and awareness of this life-threatening disease is critical.

El texto completo de este artículo está disponible en PDF.

Keywords : Mucormycosis, Diabetes mellitus, Rhizopus arrhizus


Esquema


© 2018  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 28 - N° 2

P. 269-273 - juin 2018 Regresar al número
Artículo precedente Artículo precedente
  • Les levures du clade CTG (clade Candida) : biologie, incidence en santé humaine et applications en biotechnologie
  • T.A. Defosse, Y. Le Govic, V. Courdavault, M. Clastre, P. Vandeputte, D. Chabasse, J.-P. Bouchara, N. Giglioli-Guivarc’h, N. Papon
| Artículo siguiente Artículo siguiente
  • Identification of Aspergillus tubingensis in a primary skin infection
  • M.G. Frías-De-León, E. Rosas-de Paz, R. Arenas, C. Atoche, E. Duarte-Escalante, D. Molina de Soschin, G. Acosta-Altamirano, M.R. Reyes-Montes

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.